The Efficacy of L-Carnitine for Fanconis Syndrome caused by Long-TermAdministration of Adefovir Dipivoxil(Adv) in a Patient with Chronic Hepatitis B: A Case Report
{"title":"The Efficacy of L-Carnitine for Fanconis Syndrome caused by Long-TermAdministration of Adefovir Dipivoxil(Adv) in a Patient with Chronic Hepatitis B: A Case Report","authors":"Hiroto Tanaka, H. Sasaki, M. Arita","doi":"10.4172/2167-0889.1000189","DOIUrl":null,"url":null,"abstract":"A 51-year-old female with chronic hepatitis B treated by Lamivudine (LAM) and Adefovir Dipivoxil (ADV) because of breakthrough hepatitis developed hypophosphatemia. She was diagnosed with Fanconi’s syndrome caused by the long-term administration of ADV. Since her symptoms did not improve after decreasing the ADV dosage and administering vitamin D, she was given L-carnitine. This led to a gradual improvement of her symptoms and the hypophosphatemia. These results indicate that a decrease in the ADV dose combined with supplementation with L-carnitine led to an improvement of Fanconi’s syndrome acquired by a patient with chronic hepatitis B while taking ADV.","PeriodicalId":16145,"journal":{"name":"Journal of Liver","volume":"24 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Liver","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0889.1000189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
A 51-year-old female with chronic hepatitis B treated by Lamivudine (LAM) and Adefovir Dipivoxil (ADV) because of breakthrough hepatitis developed hypophosphatemia. She was diagnosed with Fanconi’s syndrome caused by the long-term administration of ADV. Since her symptoms did not improve after decreasing the ADV dosage and administering vitamin D, she was given L-carnitine. This led to a gradual improvement of her symptoms and the hypophosphatemia. These results indicate that a decrease in the ADV dose combined with supplementation with L-carnitine led to an improvement of Fanconi’s syndrome acquired by a patient with chronic hepatitis B while taking ADV.